Sensible offers a lab-free menstrual hygiene product that screens for cervical diseases using menstrual blood. This integrated system provides an accessible, at-home screening method to improve early detection in resource-limited settings.
Funding
Funding not disclosed
Founders
Product
Problem
Many cervical cancer deaths in developing nations stem from a lack of accessible diagnostic facilities and trained personnel. This gap in healthcare infrastructure hinders early detection and timely intervention for a preventable disease.
Solution
Sensible has developed a novel, lab-free menstrual hygiene product designed to screen for cervical diseases using menstrual blood. This integrated system facilitates the collection, sampling, and analysis of biological markers directly from menses, addressing the critical need for accessible diagnostics in resource-limited settings. The product aims to empower individuals with a simple, at-home screening method, thereby improving early disease detection rates and reducing associated mortality.
Target Audience
The primary target audience includes individuals in developing nations seeking accessible cervical disease screening and healthcare providers working in underserved areas.
Features
- Integrated menstrual hygiene product for biological sample collection.
- Lab-free analysis capabilities for cervical disease screening.
- Utilizes menstrual blood (menses) as the diagnostic medium.
- Low-cost design for accessibility in developing regions.
- User-friendly interface for ease of use without specialized training.